KRAS and lung adenocarcinoma: In lung cancer cells with mutated K-ras, NF-κB is activated by the non-canonical TBK1/IκB kinase (IKK) interaction [9]; blocking IKK activity reduced tumor growth in a mouse lung adenocarcinoma model [10].